2010 Feb;95(2):953-62 33d Horie I, Abiru N, Nagayama Y, Kuriya G, Saitoh O, Ichikawa T, Iwakura Y, Eguchi K
Introduction -thalassemia is the most common inherited disease, characterized by decreased or absent -globin chain synthesis and hemoglobin A production ( The incidence of myocardial iron overload in transfusion-dependent -thalassemia patients has increased from 11.4%15.1% in early studies to 26.1%36.7% in recent studies ( As iron loading progresses, the capacity of transferrin to bind and detoxify iron is eventually exceeded, leading to non-transferrin-bound iron in plasma, which promotes oxidative stress, mitochondrial dysfunction, and ferroptosis ( Mechanisms of myocardial injury caused by iron overload Studies have shown that iron myocardial overload causes myocardial dysfunction
The on-treatment efficacy estimand showed 26.6% weight loss above placebo for the highest dose of retatrutide
Summary of laboratory model and mechanistic signaling observations Data from documented laboratory peptide signaling studies Documented interactions in GH secretagogue research models Peak elevation in research models Teichman et al., 2006 Reduced time to peak GH pulse Bowers et al., 1991 Physiologic rhythm maintenance Teichman et al., 2006 Verified in laboratory settings Raun et al., 1998 GH secretagogue research suggests pathway activity that supports protein synthesis and lipid oxidation modeling